Anticancer platinum(II) complexes bearing N-heterocycle rings

Area of Science:

• Medicinal Chemistry
• Oncology
• Materials Science

Background:

• Platinum(II) complexes have shown promise as anticancer agents.
• N-heterocycle moieties enhance the activity of platinum drugs.
• Solid tumors, especially aggressive and orphan types, require novel therapeutic strategies.

Purpose of the Study:

• To review the synthesis and anticancer activity of platinum(II) complexes with N-heterocycle moieties.
• To discuss both bifunctional and monofunctional platinum drugs, including dichloride and cationic structures.
• To evaluate in vitro and in vivo studies of these agents against various solid tumors.

Main Methods:

• Literature review of platinum(II) complex synthesis and anticancer studies.
• Analysis of structure-activity relationships for N-heterocycle-containing platinum drugs.
• Compilation of in vitro and in vivo data for efficacy assessment.

Main Results:

• Numerous platinum(II) complexes with N-heterocycle moieties exhibit significant anticancer activity.
• Both bifunctional and monofunctional platinum drugs, including dichloride and cationic forms, show therapeutic potential.
• Studies highlight efficacy against aggressive and difficult-to-treat solid tumors.

Conclusions:

• Platinum(II) complexes with N-heterocycle moieties represent a promising class of anticancer agents.
• Further research into these compounds, particularly cationic structures, may lead to new treatments for solid tumors.
• Targeting aggressive and orphan tumors with novel platinum-based drugs is a key area for future development.